Gritstone bio, Inc.
Gritstone bio, Inc. (GRTS) Stock Overview
Explore Gritstone bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.8M
P/E Ratio
-0.05
EPS (TTM)
$-1.09
ROE
-3.22%
GRTS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Gritstone bio, Inc. (GRTS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 3.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.